StockClub

RGRX

RGRXRegeneRx Biopharmaceuticals, Inc.$ --
RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2023FY2023 Q1
Revenue
0M USD
YoY -0.0%
Operating Income
-0M USD
YoY +11.3%
Net Income
-0M USD
YoY +9.2%
EPS
-0$
YoY +10.0%

Revenue

$19,190
FY2021 Q2$38,382
$38,382
Q2
FY2021 Q3$57,572
$57,572
Q3
FY2021 Q4$76,762
$76,762
Q4
FY2022 Q1$19,191
$19,191
Q1
FY2022 Q2$38,382
$38,382
Q2
FY2022 Q3$57,572
$57,572
Q3
FY2022 Q4$76,762
$76,762
Q4
FY2023 Q1$19,190
$19,190
Q1
Actual
$-1 (-0.0%)

Net Income

$-385,000
FY2021 Q2$-719,000
$-719,000
Q2
FY2021 Q3$-1.1M
$-1.1M
Q3
FY2021 Q4$-1.6M
$-1.6M
Q4
FY2022 Q1$-424,000
$-424,000
Q1
FY2022 Q2$-970,000
$-970,000
Q2
FY2022 Q3$-1.3M
$-1.3M
Q3
FY2022 Q4$-1.7M
$-1.7M
Q4
FY2023 Q1$-385,000
$-385,000
Q1
Actual
+$39,000 (+9.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2017BEAT
Actual:$56,652
Est:$53,500
FY2017BEAT
$56,652
FY2018BEAT
Actual:$69,667
Est:$50,000
FY2018BEAT
$69,667
FY2019
Actual:$76,762
FY2019
$76,762
FY2020
Actual:$76,761
FY2020
$76,761
FY2021
Actual:$76,761
FY2021
$76,761
FY2022
Actual:$76,761
FY2022
$76,761

Analyst Estimates

No forecast data